Pre-clinical results on naproxcinod in models of muscular dystrophy Pharmacy Europe Three doses of naproxcinod (10, 21 and 41mg/kg) were given orally to four-week-old mdx mice (a reference model for Duchenne Muscular Dystrophy, DMD) for nine months and compared to 0.9mg/kg of prednisolone. The results of the study suggest that ... |
